Shan Joseph 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed Feb 3, 2010
Insider Transaction Report
Form 4
Shan Joseph
VP Clin./Regulatory Affs. (3)
Transactions
- Award
Common Stock, $.001 par value
2010-02-01+25,000→ 25,436 total - Award
Incentive Stock Option (right to buy)
2010-02-01+75,000→ 154,645 totalExercise: $2.93Exp: 2020-02-01→ Common Stock (75,000 underlying)
Footnotes (4)
- [F1]These performance-based restricted shares were issued pursuant to a Stock Issuance Agreement dated February 1, 2010 and are subject to a vesting requirement based upon the timely attainment of certain predetermined clinical, financial and operational milestones. In this regard, 20% of the performance-based restricted shares will vest upon the attainment of each predetermined milestone, which have targeted completion dates ranging from June 30, 2010 through July 15, 2011.
- [F2]Includes performance-based restricted shares issued pursuant to a Stock Issuance Agreement dated February 1, 2010.
- [F3]Option will vest quarterly in equal installments over a two year period.
- [F4]n/a